4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-23-004315
EVP, CHIEF FINANCIAL OFFICER sold 184 shares at $8.89 ($1,636)
- EVP, CHIEF FINANCIAL OFFICER acquired 31,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 2023-03-02 | Grant or award | +31,500 | 107,743 | D | ||
| ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 2023-03-03 | Sale | −184 | $8.89 | $1,636 | 107,559 | D |
| Derivatives | |||||||
| ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 2023-03-02 | Grant or award · Stock Option (right to buy) | +94,500 | 94,500 | D | ||
| Open-market sales · 184 sh · avg $8.89 · $1,636 | |||||||
Loading xslF345X03/form4-03062023_040309.xml…